Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Increased genomic surveillance capacity during the pandemic allowed researchers to get a deeper insight into the global distribution patterns of seasonal flu and other respiratory viruses.

Man in mask getting his temperature taken at airport during COVID-19 pandemic

In a new study published in Science, an international team of researchers – including scientists from NDM’s Pandemic Sciences Institute and the Department of Biology – combined data on the spread of seasonal influenza, its genetic makeup and international travel patterns to study how seasonal flu viruses moved and evolved. 

This approach helped to estimate how long the viruses remained in certain regions during periods of high and low volumes of international travel and how their genetic diversity changed before, during and after the COVID-19 pandemic.

During the COVID-19 pandemic, seasonal influenza levels dropped worldwide due to restrictions on population movement and mixing. However, the subsequent rapid bounce-back of influenza once air travel returned to pre-pandemic levels showed that the virus was in most cases maintained during the pandemic with continued viral movements and accumulation of genetic diversity.

Lead author Zhiyuan Chen from Fudan University said: ‘It was remarkable how quickly seasonal flu re-established to a pre-pandemic equilibrium just a few years after the height of the COVID-19 pandemic.’

Tropical climates, like those found across South and East Asia, allow for continued flu transmission year-round, thereby creating a broader range of flu strains and increasing overall viral diversity. 

The increased capacity for virus genomic surveillance during the COVID-19 pandemic provided more detail on the role of other regions, such as Africa and West Asia, in the global circulation of influenza. These regions also showed evidence of sustained transmission and during the pandemic had relatively less restrictions on movement, in part due to lower levels of COVID-19 transmission.

Professor Moritz Kraemer, Principal Investigator at PSI, said: ‘Increased genomic surveillance capacity established during the COVID-19 pandemic means that we are finally getting a deeper insight into the global distribution patterns of seasonal flu and other respiratory viruses. These novel and large openly accessible datasets provide an opportunity to learn about the intricate relationships of climate, co-circulating viruses, and human behaviour.’

Further, with this increased global capacity for surveillance of viruses it might be possible to better monitor seasonal influenza to reduce the risk of vaccine mismatches, help inform more effective interventions, and reduce the burden of seasonal influenza on our healthcare systems. This is especially relevant as more regions become suitable for year-round circulation of influenza with changes in climatic conditions.

Professor Hongjie Yu from Fudan University said: ‘Further efforts should still focus on the continuing surveillance of seasonal influenza viruses and other respiratory pathogens, particularly resource-limited regions. The established surveillance systems for seasonal respiratory pathogens could also play an extremely vital role when the next pandemic emerges in the future.’

Interested in finding out more? Read the full paper on the Science website: https://doi.org/10.1126/science.adq3003.

Similar stories

Building the world's evidence base to tackle drug-resistant tuberculosis

£10 million international research programme launches across India, Kazakhstan, Mozambique, South Africa and Vietnam.

A New Layer of Control for a Decades-Old Leukemia Drug

How cells respond to the leukemia drug 6-thioguanine still holds surprises: A new study, led jointly by researchers from CeMM and the University of Oxford identifies NUDT5 as an unexpected regulator of drug sensitivity and reveals that its role has nothing to do with its enzymatic activity.

Team ATLAS sets out strategy to investigate cancer avoidance as part of Cancer Grand Challenges

A new position paper from team ATLAS sets out plans to build a cancer antibody atlas to investigate why some people avoid cancer, while others develop disease.

Decades old puzzle solved as scientists uncover cause of inflammatory bowel disease

Scientists have identified the missing link between a long-known genetic signal in inflammatory bowel disease and a damaging immune response that switches off the body’s natural control of inflammation - opening the door to faster diagnosis and targeted treatment.

Oxford Bundibugyo ebolavirus vaccine candidate receives CEPI backing

The Coalition for Epidemic Preparedness Innovations (CEPI) has announced today that it will urgently accelerate the development of three investigational vaccines targeting the Bundibugyo ebolavirus that has caused a rapidly spreading epidemic in the Democratic Republic of the Congo (DRC) and neighbouring Uganda, including one being developed by the Oxford Vaccine Group at the University of Oxford.

New study improves early detection of life threatening infection in children across South and South East Asia

A new study published in Nature Medicine suggests that simple, low-cost tools could help health workers identify children at risk of life-threatening infection earlier, improving access to urgent care in across South and South East Asia.